Does aspirin make an impact on spine surgery for cardiac patients? 6 key notes

Written by Laura Dyrda | May 05, 2015 | Print  |

A new study published in Spine examines the impact of aspirin on patients with cardiac stents undergoing spine surgery.

The study includes 200 patients, with 100 who underwent spine surgery after discontinuing anticolagulation therapy and 100 who continued to take the daily aspirin through the perioperative period.


The researchers found:


1. The patients who continued taking aspirin had a shorter hospital length of stay on average than the other patients.


2. The patients who continued to take aspirin also reported reduced operative time.


3. There was no significant difference in estimated blood loss between both groups.


4. Overall intra- and postoperative complications were 8 percent for the patients who continued taking aspirin, compared with 11 percent for the patients who did not.


5. The 30-day readmission rate was the same between both groups — 5 percent.


6. There wasn't a clinically significant spinal epidural hematomas observed during the study in either groups.


"Although very large studies will be needed to determine whether aspirin administration results in a small complication rate increase, the current study provides evidence that perioperative aspirin therapy is relatively safe in patients undergoing spinal surgery," concluded the study authors.


More articles on spine surgery:
Dr. Paul Rubery to chair University of Rochester Medical Center's orthopedics department
Another Medicare Administrative Contractor to cover MIS SI joint fusions
Spinal fusion patients—Can preoperative cognitive-behavioral intervention help?

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers